Haloperidol secreted in breast milk.

Area of Science:

• Pharmacology
• Neonatal Health
• Psychiatry

Background:

• Puerperal psychosis is a severe postpartum mental health condition.
• Treatment often involves antipsychotic medications like haloperidol.
• Concerns exist regarding medication transfer to infants via breastfeeding.

Observation:

• A mother with puerperal psychosis received haloperidol 5 mg twice daily.
• She breastfed her infant under hospital supervision.
• Haloperidol levels in breast milk were measured up to 23.5 micrograms/l.

Findings:

• The breastfed infant showed no signs of sedation.
• The infant maintained good feeding habits.
• The infant demonstrated normal growth and development.

Implications:

• Short-term maternal haloperidol use may be compatible with breastfeeding.
• This suggests a potentially favorable risk-benefit balance for specific clinical scenarios.
• Further research is warranted to confirm long-term safety and efficacy.